AGN News and Press, Allergan plc From 07/16/19

Millendo Therapeutics (NASDAQ: MLND ) initiated with Outperform rating and $26 (141% upside) at Oppenheimer. More news on: Viking Therapeutics, Inc., Millendo Therapeutics, Inc., Laboratory Corporation of America Holdings, Healthcare stocks news, Stocks on the move, , Read more ...

In a recent article, I ranked the Dividend Aristocrats using a modified version of David Van Knapp 's quality scoring system . The system employs five widely used quality indicators from independent sources and assigns 0-5 points to each quality indicator, for a maximum of 25 points. Whi...

Merger activity remained steady last week with three new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Acacia Communications (ACIA) by Cisco Systems (CSCO) for $2.6 billion or $70.00 per share in cash. The spread for an all-cash dea...

by Daniel Shvartsman The first half of 2019 saw a lot of green in the markets, as broader indices recovered from the brief bear market in the second half of 2018 and returned to new heights. Despite that, the wall of worry continued to grow, even if the specific concerns changed. Instead o...

By now, just about everyone has heard about AbbVie’s ( ABBV ) bid to acquire Allergan ( AGN ). If you haven’t already, I encourage you to view the investor presentation . For a deeper look, also consider reading my previous article, Merger Math: Allergan + AbbVie . I also recom...

NEW YORK, July 12, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating the following companies: Del Frisco’s Restaurant Group, Inc. (NASDAQ: DFRG) The investigation concerns whether Del Frisco’s and its board of directors violate...

Major drug makers are under water nearing the close as skittish investors move the sidelines ahead of President Trump's plan to peg Medicare reimbursement to the lowest ex-U.S. prices from a select group of countries. More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Heal...

(Source: Imgflip ) While there are many ways to invest in dividends stocks, my personal favorite (shared with my two fellow Dividend Kings Brad Thomas and Chuck Carnevale) is value investing. That's because buying quality companies at a large discount to fair value is how seven of the e...

Prior to the announced merger with Allergan ( AGN ) AbbVie ( ABBV ) had already been a complicated stock to understand. On the one hand, you had a fantastic dividend growth stock with a 5% and higher yield, double-digit earnings and dividend growth and the world's best-selling drug ever as i...

I'm bullish on AbbVie ( ABBV ). It remains one of my largest pharma stocks, and I'm willing to add more, should the opportunity present itself. And I believe that it now has, and may even improve going forward. In this article, we'll take an updated look at the proposed merger between AbbVie...